GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abnova (Taiwan) Corp (TPE:4133) » Definitions » Total Equity

Abnova (Taiwan) (TPE:4133) Total Equity : NT$1,295.2 Mil (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Abnova (Taiwan) Total Equity?

Abnova (Taiwan)'s total equity for the quarter that ended in Sep. 2024 was NT$1,295.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Abnova (Taiwan) Total Equity Historical Data

The historical data trend for Abnova (Taiwan)'s Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abnova (Taiwan) Total Equity Chart

Abnova (Taiwan) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,192.40 1,211.09 1,211.76 1,291.99 1,286.32

Abnova (Taiwan) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,280.51 1,286.32 1,272.99 1,292.21 1,295.25

Abnova (Taiwan) Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Abnova (Taiwan)'s Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1355.743-69.424
=1,286.3

Abnova (Taiwan)'s Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=1372.453-77.204
=1,295.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abnova (Taiwan) Total Equity Related Terms

Thank you for viewing the detailed overview of Abnova (Taiwan)'s Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abnova (Taiwan) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abnova (Taiwan) Corp (TPE:4133) » Definitions » Total Equity
Comparable Companies
ROCO:6892 TPE:3164 ROCO:6846 ROCO:4171 ROCO:6879 ROCO:4186 ROCO:4195 ROCO:6580 ROCO:3205 ROCO:6827 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No.108, Jhouzih Street, 9th Floor, Neihu District, Taipei City, TWN
Website
https://www.abnova.com
Abnova (Taiwan) Corp is a manufacturer of antibody and recombinant protein, including monoclonal antibodies, polyclonal antibodies, and protein-related products.

Abnova (Taiwan) Headlines

No Headlines